NCT00447122View on ClinicalTrials.gov

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Metastatic Pancreatic Cancer
Interventions
DRUG

Gemcitabine 1000mg/m2 30 minutes

1000mg/m2 30 minutes

DRUG

Lapatinib 1000mg/d

1000mg/d

DRUG

Lapatinib 1500mg/d

1500mg/d

DRUG

Gemcitabine 1000mg/m2 100minutes

1000mg/m2 100minutes

DRUG

Oxaliplatin 100mg/m2

100mg/m2

Trial Locations (1)

02903

Lifespan Hospitals, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

The Miriam Hospital

OTHER

collaborator

Memorial Hospital of Rhode Island

OTHER

lead

Brown University

OTHER